Toronto/Canada, 23 May 2006 – The antidepressant duloxetine was significantly better, across a studied dose range of 40-120 mg per day, at reducing symptoms of depression than a group of commonly used selective serotonin reuptake inhibitor (SSRIs) antidepressants, according to a post hoc analysis of pooled data from seven studies that included more than 2,400 patients.
